Open AccessCould Molnupiravir Have an Ameliorative Effect in Pets with COVID-19?
Publication year - 2022
Publication title -
letters in applied nanobioscience
Language(s) - English
Resource type - Journals
ISSN - 2284-6808
DOI - 10.33263/lianbs124.120
Subject(s) - medicine , vaccination , adverse effect , covid-19 , coronavirus , intensive care medicine , tocilizumab , feline infectious peritonitis , pandemic , intensive care , virology , pharmacology , infectious disease (medical specialty) , disease